Can a GLP-1 Medication Help Treat Binge Eating?
The use of GLP-1 for a binge eating disorder is evolving as a potentially transformative adjunctive approach for treatment.
The use of GLP-1 for a binge eating disorder is evolving as a potentially transformative adjunctive approach for treatment.
While advancements such as GLP-1 medications and bariatric surgery have improved clinical outcomes, a persistent gap remains in the use of behavioral interventions for weight management.
As with other GLP-1 medications, tirzepatide is currently not recommended for pregnant women or those planning to conceive.
Although semaglutide is generally considered to be safe, it is not recommended for women who are pregnant or trying to become pregnant.
Pharmacotherapy for Weight Loss and Type 2 Diabetes
While diet and exercise remain the cornerstones of any successful weight loss program, the integration of meal replacements and weight loss medications has emerged as powerful companions. If you are a health care professional working with patients who…
Weight loss physicians are increasingly finding themselves at a crossroad when it comes to science and sales. It’s time to embrace the synergy this combination creates for you and your patients. If you enter an extremely successful medical weight loss…
High quality nutritional products can positively impact the overall success of a medically-supervised comprehensive weight management plan. According to the National Institutes of Health, nearly three in four adults age 20 or older in the United States are overweight or…